See more ads for:
- Reuters via Yahoo! NewsMay 24 09:58 AM
By Kate Kelland LONDON (Reuters) - People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication, the world's leading diabetes groups said. A joint statement from a 45-strong group said on Tuesday that bariatric, or metabolic, surgery could have a significant benefit for hundreds of thousands of patients worldwide ...
Experts Urge Surgery To Cure Type-2 Diabetes - Sky News via Yahoo Canada News
Type 2 diabetes: weight-loss surgery should be a... - Sydney Morning Herald
- CBS NewsMay 24 06:07 PM
New medical guidelines suggest many diabetes patients could benefit from weight-loss surgery. New guidelines say weight-loss surgery should become a more routine treatment option for diabetes, even for some patients who are mildly obese.
Consider obesity surgery more often for diabetes... - Boston Herald
Guidelines urge obesity surgery for diabetes - Hamilton Spectator
- BBC NewsMay 24 07:30 AM
Thousands of people with type-2 diabetes in the UK are missing out on obesity surgery that would slash blood sugars and even lead to remission in some cases, a team of experts say.
Surgery Can Treat Diabetes, Groups Agree - NBC NEWS
Use obesity surgery more often for diabetes, gui... - Boston Herald
- Associated Press via Yahoo! NewsMay 24 12:36 PM
WASHINGTON (AP) — New guidelines say weight-loss surgery should become a more routine treatment option for diabetes, even for some patients who are mildly obese.
- Reuters via Yahoo! NewsMay 24 11:25 PM
A U.S. advisory panel on Tuesday recommended approval of a new diabetes drug made by Novo Nordisk A/S that combines two of its existing treatments in a fixed-dose combination designed to be both effective and convenient. The panel voted 16-0 that the Food and Drug Administration should approve the drug, iDegLira, for patients with type 2 diabetes. The FDA is not obliged to follow the advice of ...
- Market Realist via Yahoo! FinanceMay 24 12:06 PM
Sanofi's (SNY) Cardiovascular franchise includes Praluent and Multaq. Praluent, an injection for lowering LDL cholesterol, was launched in collaboration with Regeneron in July 2015 in the US markets, where ...
- Reuters via Yahoo! FinanceMay 23 07:46 AM
The Sanofi executive in charge of diabetes and cardiovascular products, Pascale Witz, will leave the French drugmaker on June 1 as part of a management shake-up, the company said on Monday. The departure of Witz, executive vice president for diabetes and cardiovascular products, is one of a number of changes to Sanofi's executive committee that the company said were designed to support a five ...
- Business Wire via Yahoo! FinanceMay 23 02:30 AM
Physicians working with patients being evaluated and treated for type 2 diabetes now have access to an in-depth, point-of-care app, compliments of the American Association of Clinical Endocrinologists and the American College of Endocrinology .
- Zacks via Yahoo! FinanceMay 24 05:07 AM
Sanofi's (SNY) diabetes combination drug will be coming up for review by an FDA advisory panel this week.
- Business Wire via Yahoo! FinanceMay 23 01:55 AM
The opening speaker at the American Association of Clinical Endocrinologists’ 25th Annual Scientific & Clinical Congress said today that although recent discoveries about human gut microbiome and its relationship to diabetes are promising, a number of hurdles must be overcome before microbiome’s potential to contribute to diabetes prevention or treatment therapy can be realized.
See more ads for: